Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Research Report 2023

Publication ID:

PB502241990

Publication Date:

February 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Biopharmaceuticals Manufacturing Consumables Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biopharmaceuticals Manufacturing Consumables Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biopharmaceuticals Manufacturing Consumables Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biopharmaceuticals Manufacturing Consumables Testing in Pharma and Biological is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biopharmaceuticals Manufacturing Consumables Testing include Alcami Corporation, Merck KGaA, Eurofins Scientific, Agilent Technologies, Charles River, Catalent, Inc., Avomeen Analytical Services, BioSpectra and Pace Analytical Services, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals Manufacturing Consumables Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals Manufacturing Consumables Testing.
The Biopharmaceuticals Manufacturing Consumables Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biopharmaceuticals Manufacturing Consumables Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceuticals Manufacturing Consumables Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Alcami Corporation
Merck KGaA
Eurofins Scientific
Agilent Technologies
Charles River
Catalent, Inc.
Avomeen Analytical Services
BioSpectra
Pace Analytical Services
Segment by Type
Chemical Analysis Testing
Enzyme Testing
Stability Testing
Sterility Testing
Others
Segment by Application
Pharma and Biological
Medical Devices
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceuticals Manufacturing Consumables Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemical Analysis Testing
1.2.3 Enzyme Testing
1.2.4 Stability Testing
1.2.5 Sterility Testing
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharma and Biological
1.3.3 Medical Devices
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Perspective (2018-2029)
2.2 Biopharmaceuticals Manufacturing Consumables Testing Growth Trends by Region
2.2.1 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biopharmaceuticals Manufacturing Consumables Testing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Biopharmaceuticals Manufacturing Consumables Testing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Dynamics
2.3.1 Biopharmaceuticals Manufacturing Consumables Testing Industry Trends
2.3.2 Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Drivers
2.3.3 Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Challenges
2.3.4 Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceuticals Manufacturing Consumables Testing Players by Revenue
3.1.1 Global Top Biopharmaceuticals Manufacturing Consumables Testing Players by Revenue (2018-2023)
3.1.2 Global Biopharmaceuticals Manufacturing Consumables Testing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceuticals Manufacturing Consumables Testing Revenue
3.4 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Concentration Ratio
3.4.1 Global Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Manufacturing Consumables Testing Revenue in 2022
3.5 Biopharmaceuticals Manufacturing Consumables Testing Key Players Head office and Area Served
3.6 Key Players Biopharmaceuticals Manufacturing Consumables Testing Product Solution and Service
3.7 Date of Enter into Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceuticals Manufacturing Consumables Testing Breakdown Data by Type
4.1 Global Biopharmaceuticals Manufacturing Consumables Testing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Biopharmaceuticals Manufacturing Consumables Testing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Biopharmaceuticals Manufacturing Consumables Testing Breakdown Data by Application
5.1 Global Biopharmaceuticals Manufacturing Consumables Testing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Biopharmaceuticals Manufacturing Consumables Testing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size (2018-2029)
6.2 North America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2018-2023)
6.4 North America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size (2018-2029)
7.2 Europe Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size (2018-2029)
9.2 Latin America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alcami Corporation
11.1.1 Alcami Corporation Company Detail
11.1.2 Alcami Corporation Business Overview
11.1.3 Alcami Corporation Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.1.4 Alcami Corporation Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.1.5 Alcami Corporation Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.2.4 Merck KGaA Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.2.5 Merck KGaA Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Detail
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.3.4 Eurofins Scientific Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.3.5 Eurofins Scientific Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.4.4 Agilent Technologies Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Charles River
11.5.1 Charles River Company Detail
11.5.2 Charles River Business Overview
11.5.3 Charles River Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.5.4 Charles River Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.5.5 Charles River Recent Development
11.6 Catalent, Inc.
11.6.1 Catalent, Inc. Company Detail
11.6.2 Catalent, Inc. Business Overview
11.6.3 Catalent, Inc. Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.6.4 Catalent, Inc. Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.6.5 Catalent, Inc. Recent Development
11.7 Avomeen Analytical Services
11.7.1 Avomeen Analytical Services Company Detail
11.7.2 Avomeen Analytical Services Business Overview
11.7.3 Avomeen Analytical Services Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.7.4 Avomeen Analytical Services Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.7.5 Avomeen Analytical Services Recent Development
11.8 BioSpectra
11.8.1 BioSpectra Company Detail
11.8.2 BioSpectra Business Overview
11.8.3 BioSpectra Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.8.4 BioSpectra Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.8.5 BioSpectra Recent Development
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Detail
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biopharmaceuticals Manufacturing Consumables Testing Introduction
11.9.4 Pace Analytical Services Revenue in Biopharmaceuticals Manufacturing Consumables Testing Business (2018-2023)
11.9.5 Pace Analytical Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Alcami Corporation
Merck KGaA
Eurofins Scientific
Agilent Technologies
Charles River
Catalent, Inc.
Avomeen Analytical Services
BioSpectra
Pace Analytical Services

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.